Head-to-head · Cost-Efficiency Index
altRX vs Andrew Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
altRX
Cost-first shoppers who want locking in a flat, same-at-every-dose promotional rate before it expires.
Visit altRXAndrew Meds
Shoppers comparing published monthly rates who are willing to check that the price on the page is the price the checkout charges.
Visit Andrew MedsThe verdict
altRX and Andrew Meds tie on the Cost-Efficiency Index at 70/100, so neither wins outright on the numbers. For most shoppers we'd start with altRX (ranked #78, a hair above #83) — Cost-first shoppers who want locking in a flat, same-at-every-dose promotional rate before it expires. But Andrew Meds is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs altRX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | altRX | Andrew Meds |
|---|---|---|
| Cost-Efficiency Index | 70/100 | 70/100 |
| Semaglutide / mo | $89/mo (all doses, promotional rate, plus a separate fee, compounded) | $199/month month-to-month (the intake this page opens sells a $99 low-dose program instead) |
| Tirzepatide / mo | $149/mo (all doses, promotional rate, compounded) | $299/month month-to-month |
| Semaglutide / yr (modeled) | $1,068 | $2,388 |
| Tirzepatide / yr (modeled) | $1,788 | $3,588 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #78 | #83 |
altRX
70/100Where the value is
- Same price at every dose — titrating up does not raise the monthly cost, unlike per-mg-tiered competitors
- No membership fee, no insurance required; price stated to be all-in (consultation, dosing plan, medication, free delivery, clinician support)
- LegitScript certified
The tradeoffs
- The advertised $89/$149 prices are an explicitly time-limited promotion with a live countdown on the page — the standing price is roughly double, and a naive reading of the headline as a stable price would be wrong within about a week of this research
- No compounding pharmacy is individually named, only '503A compounding pharmacies within the altRx network'
Regulatory note: the FDA issued a warning letter to Trinity HealthCare Supply, LLC dba altRx in June 2026. We still list and link to altRX; you should know the letter is on the public record before you decide.
Andrew Meds
70/100Where the value is
- Full month-to-month and prepay ladders for both molecules are printed on the product pages, before any intake
- States which pharmacy class fills a prescription — "a 503(A) compounding pharmacy or 503(B) outsourcing facility" — which most sellers at this price leave unsaid
- Names the prescribing practice, with a street address and a direct phone line, in the footer of every page
The tradeoffs
- Three live semaglutide prices disagree: $199 a month on the product page, $99 a month in the intake that page links to, and $149 for a four-week supply in a second funnel
- The tirzepatide page's own funnel offers only semaglutide, so the $299 tirzepatide price cannot be bought through the route the page provides
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.